DE3851002D1 - Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung. - Google Patents

Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung.

Info

Publication number
DE3851002D1
DE3851002D1 DE3851002T DE3851002T DE3851002D1 DE 3851002 D1 DE3851002 D1 DE 3851002D1 DE 3851002 T DE3851002 T DE 3851002T DE 3851002 T DE3851002 T DE 3851002T DE 3851002 D1 DE3851002 D1 DE 3851002D1
Authority
DE
Germany
Prior art keywords
linear
alpha
cyclic analogs
extraordinary effects
msh fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3851002T
Other languages
English (en)
Other versions
DE3851002T2 (de
Inventor
Victor J Hruby
Fahad A Al-Obeidi
Mac E Hadley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Competitive Technologies Inc
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Application granted granted Critical
Publication of DE3851002D1 publication Critical patent/DE3851002D1/de
Publication of DE3851002T2 publication Critical patent/DE3851002T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68Melanocyte-stimulating hormone [MSH]
    • C07K14/685Alpha-melanotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DE3851002T 1987-05-22 1988-05-19 Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung. Expired - Lifetime DE3851002T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5322987A 1987-05-22 1987-05-22
CA000578920A CA1340107C (en) 1987-05-22 1988-09-30 Linear and cyclic analoques of alpha-msh fragments with extraordinary potency

Publications (2)

Publication Number Publication Date
DE3851002D1 true DE3851002D1 (de) 1994-09-15
DE3851002T2 DE3851002T2 (de) 1995-02-02

Family

ID=25672150

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3851002T Expired - Lifetime DE3851002T2 (de) 1987-05-22 1988-05-19 Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung.

Country Status (11)

Country Link
EP (1) EP0292291B1 (de)
JP (1) JPH0826077B2 (de)
CN (1) CN1031242C (de)
AT (1) ATE109793T1 (de)
CA (1) CA1340107C (de)
DE (1) DE3851002T2 (de)
DK (1) DK172760B1 (de)
FI (1) FI882380A (de)
IE (1) IE64903B1 (de)
PH (1) PH25819A (de)
PT (1) PT87560B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
US5683981A (en) * 1987-05-22 1997-11-04 Competitive Technologies, Inc. Cyclic bridged analogs of α-MSH and methods thereof
EP0389950A1 (de) * 1989-03-23 1990-10-03 Lion Corporation Inhibitor des melanocytenstimulierenden Hormons und dieses enthaltendes, äusserlich anwendbares Präparat
US5071583A (en) * 1990-08-14 1991-12-10 Steve Martell Soap bar having a fifth finger gripping member
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5364851A (en) * 1991-06-14 1994-11-15 International Synthecon, Llc Conformationally restricted biologically active peptides, methods for their production and uses thereof
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
JP3204510B2 (ja) * 1993-04-05 2001-09-04 コンペティティブ テクノロジーズ,インク. 勃起不全の診断および治療
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5420109A (en) * 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
CA2368431C (en) 1999-03-29 2006-01-24 The Procter & Gamble Company Melanocortin receptor ligands
TW200716979A (en) * 1999-06-29 2007-05-01 Univ New York Screening methods for compounds that affect melanogenesis
DE10228837B4 (de) * 2002-06-27 2016-01-07 Elfriede Rauch Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
MXPA06003474A (es) 2003-09-30 2006-06-05 Novo Nordisk As Agonistas de receptores de melanocortina.
JP5449673B2 (ja) * 2004-10-08 2014-03-19 クリヌベール、ファーマスーティカルズ、リミテッド 対象者におけるメラニン形成を誘導するための組成物および方法
CN100355776C (zh) * 2005-06-20 2007-12-19 中国人民解放军第二军医大学 一种新型α-黑素细胞刺激素类似物及其用途
KR20080041639A (ko) 2005-07-08 2008-05-13 소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. 멜라노코르틴 수용체의 리간드
NO2957292T3 (de) 2008-03-27 2018-05-12
KR101687037B1 (ko) 2008-06-09 2016-12-15 팔라틴 테크놀로지스 인코포레이티드 성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
US8338565B2 (en) 2008-08-20 2012-12-25 Ensemble Therapeutics Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
EA201290295A1 (ru) 2009-11-23 2013-01-30 Палатин Текнолоджиз, Инк. Специфичные к рецептору меланокортина-1 линейные пептиды
NZ599774A (en) 2009-11-23 2014-11-28 Palatin Technologies Inc Melanocortin-1 receptor-specific cyclic peptides
CN102816211B (zh) * 2012-09-10 2014-07-23 南京工业大学 一种制备美那诺坦的方法
EP3450449A3 (de) * 2013-03-15 2019-06-12 Rhythm Pharmaceuticals, Inc. Peptidzusammensetzungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US448539A (en) 1891-03-17 Cornelius s morris
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin

Also Published As

Publication number Publication date
IE881537L (en) 1988-11-22
IE64903B1 (en) 1995-09-20
EP0292291A2 (de) 1988-11-23
PT87560B (pt) 1992-09-30
PH25819A (en) 1991-11-05
EP0292291A3 (en) 1990-05-02
FI882380A0 (fi) 1988-05-20
EP0292291B1 (de) 1994-08-10
DE3851002T2 (de) 1995-02-02
JPS6470499A (en) 1989-03-15
CA1340107C (en) 1998-10-27
AU1650688A (en) 1988-11-24
DK277788D0 (da) 1988-05-20
CN1032795A (zh) 1989-05-10
JPH0826077B2 (ja) 1996-03-13
FI882380A (fi) 1988-11-23
CN1031242C (zh) 1996-03-13
PT87560A (pt) 1989-05-31
ATE109793T1 (de) 1994-08-15
AU618733B2 (en) 1992-01-09
DK277788A (da) 1988-11-23
DK172760B1 (da) 1999-06-28

Similar Documents

Publication Publication Date Title
DE3851002T2 (de) Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung.
ATE358176T1 (de) Menschliche dnase
FR2712286B1 (fr) Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation.
ES2036526T3 (es) Composiciones de interferon.
NO180636C (no) Fremgangsmåte for fremstilling av et rent O-glycosylert IGF-1
DK67683A (da) Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
IT8723062A0 (it) Procedimento e dispositivo per registrare punti morti di filatura o torcitura.
FR2622103B1 (fr) Nouvelles compositions dermatologiques bronzantes insectifuges
EP0266665A3 (en) Treatment of inflammatory articular diseases
DE3674997D1 (de) Holzbehandlungszusammensetzung.
ATE87314T1 (de) Platin-arzneimittel.
MY104115A (en) Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
DE3586321D1 (de) Verwendung von 1,4-dihydropyridinderivaten.
RO88118A2 (ro) Sursa de tensiune stabilizata in comutatie
BR6601768U (pt) Disposicao construtiva em maca deslizavel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: COMPETITIVE TECHNOLOGIES, INC. (N.D.GES.D. STAATES